METHOD FOR INTRODUCING DOTA
    4.
    发明申请
    METHOD FOR INTRODUCING DOTA 审中-公开
    引言DOTA的方法

    公开(公告)号:US20110237774A1

    公开(公告)日:2011-09-29

    申请号:US13123137

    申请日:2009-10-09

    IPC分类号: C07K1/113 C07H1/00

    摘要: The invention provides a method for introducing 1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetraacetic acid (DOTA) into a compound such as a peptide. The method comprises a first step for preparing a mixed liquid of DOTA having no protecting group and dimethylsulfoxide, and a second step for contacting the mixed liquid with the compound carried on a solid-phase carrier.

    摘要翻译: 本发明提供了将1,4,7,10-四氮杂环十二烷-N,N',N“,N” - 四乙酸(DOTA)引入化合物如肽中的方法。 该方法包括:制备没有保护基和二甲基亚砜的DOTA的混合液的第一步骤,以及使混合液与载持在固相载体上的化合物接触的第二步骤。

    Isocarbacyclin derivatives
    8.
    发明授权
    Isocarbacyclin derivatives 失效
    异卡环素衍生物

    公开(公告)号:US5700833A

    公开(公告)日:1997-12-23

    申请号:US594152

    申请日:1996-01-31

    CPC分类号: C07C59/54

    摘要: The present invention provides novel isocarbacyclin derivatives useful for search and study of prostacyclin receptor and as a therapeutic drug for central nervous system diseases, which derivatives are expressed by the following formula �I!: ##STR1## �where, R.sup.1 represents a hydrogen atom, an alkyl group, or cation of an appropriate amount, and R.sup.2 an alkylene group.!

    摘要翻译: 本发明提供了可用于前列环素受体的研究和研究的新型异卡波环素衍生物,作为中枢神经系统疾病的治疗药物,该衍生物由下式[I]表示:其中,R1表示 氢原子,烷基或适当量的阳离子,R 2为亚烷基。